These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28431278)

  • 21. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.
    Woolley JD; Chuang B; Fussell C; Scherer S; Biagianti B; Fulford D; Mathalon DH; Vinogradov S
    Psychol Med; 2017 May; 47(7):1311-1322. PubMed ID: 28091349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.
    Goldman MB; Gomes AM; Carter CS; Lee R
    Psychopharmacology (Berl); 2011 Jul; 216(1):101-10. PubMed ID: 21301811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional MRI study on how oxytocin affects decision making in social dilemmas: Cooperate as long as it pays off, aggress only when you think you can win.
    Lambert B; Declerck CH; Boone C; Parizel PM
    Horm Behav; 2017 Aug; 94():145-152. PubMed ID: 28676252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans.
    Feng C; Lori A; Waldman ID; Binder EB; Haroon E; Rilling JK
    Genes Brain Behav; 2015 Sep; 14(7):516-25. PubMed ID: 26178189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin.
    Busnelli M; Dagani J; de Girolamo G; Balestrieri M; Pini S; Saviotti FM; Scocco P; Sisti D; Rocchi M; Chini B
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26715485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal Oxytocin Selectively Modulates Large-Scale Brain Networks in Humans.
    Brodmann K; Gruber O; Goya-Maldonado R
    Brain Connect; 2017 Sep; 7(7):454-463. PubMed ID: 28762756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.
    Feifel D; Macdonald K; Nguyen A; Cobb P; Warlan H; Galangue B; Minassian A; Becker O; Cooper J; Perry W; Lefebvre M; Gonzales J; Hadley A
    Biol Psychiatry; 2010 Oct; 68(7):678-80. PubMed ID: 20615494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
    Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intranasal oxytocin on satiety signaling in people with schizophrenia.
    Warren KR; Wehring HJ; Liu F; McMahon RP; Chen S; Chester C; Kelly DL
    Physiol Behav; 2018 May; 189():86-91. PubMed ID: 29524451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
    van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
    Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
    Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of adjunctive intranasal oxytocin in patients with schizophrenia.
    Ota M; Yoshida S; Nakata M; Yada T; Kunugi H
    Postgrad Med; 2018 Jan; 130(1):122-128. PubMed ID: 29105546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.
    Andreou C; Moritz S; Veith K; Veckenstedt R; Naber D
    Schizophr Bull; 2014 May; 40(3):558-65. PubMed ID: 23661634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of conservatism and jumping to conclusions biases with aberrant salience and default mode network.
    Miyata J; Sasamoto A; Ezaki T; Isobe M; Kochiyama T; Masuda N; Mori Y; Sakai Y; Sawamoto N; Tei S; Ubukata S; Aso T; Murai T; Takahashi H
    Psychiatry Clin Neurosci; 2024 May; 78(5):322-331. PubMed ID: 38414202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin Effect on Collective Decision Making: A Randomized Placebo Controlled Study.
    Hertz U; Kelly M; Rutledge RB; Winston J; Wright N; Dolan RJ; Bahrami B
    PLoS One; 2016; 11(4):e0153352. PubMed ID: 27070542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.
    Feifel D; Macdonald K; Cobb P; Minassian A
    Schizophr Res; 2012 Aug; 139(1-3):207-10. PubMed ID: 22682705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.